Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 79,047 | 79,790 | 89,690 | 75,543 | 71,040 |
| Cost of Goods | 46,660 | 48,887 | 55,001 | 46,283 | 44,976 |
| Gross Profit | 32,387 | 30,903 | 34,689 | 29,260 | 26,064 |
| Operating Expenses | 32,074 | 34,962 | 33,145 | 26,993 | 29,981 |
| Operating Income | 973 | -3,172 | 1,545 | 2,550 | -2,941 |
| Interest Expense | 24 | 30 | 1 | 124 | 100 |
| Other Income | 60,144 | -431 | -955 | 148 | -1,159 |
| Pre-tax Income | 61,093 | -3,633 | 589 | 2,574 | -4,200 |
| Income Tax | 14,173 | -1,479 | -1,129 | 958 | -1,347 |
| Net Income Continuous | 46,920 | -2,154 | 1,718 | 1,616 | -2,853 |
| Minority Interests | -867 | -3,022 | -149 | -773 | N/A |
| Net Income | $47,787 | $868 | $1,867 | $2,389 | $-2,853 |
| EPS Basic Total Ops | 1.01 | 0.02 | 0.04 | 0.05 | -0.06 |
| EPS Basic Continuous Ops | 1.00 | -0.05 | 0.04 | 0.03 | -0.06 |
| EPS Diluted Total Ops | 0.96 | 0.02 | 0.04 | 0.05 | -0.06 |
| EPS Diluted Continuous Ops | 0.94 | -0.04 | 0.04 | 0.03 | -0.06 |
| EBITDA(a) | $5,382 | $1,256 | $5,925 | $6,722 | $1,234 |